| Date Filed | Type | Description |
| 05/15/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 05/12/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/10/2023 |
8-K
| Other Events Interactive Data |
| 05/01/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/13/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/05/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/14/2022 |
SC 13G
| LAVA Medtech Sponsor LP reports a 20% stake in LAVA Medtech Acquisition Corp. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2021 |
8-K
| Quarterly results |
| 12/10/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/08/2021 |
SC 13G
| Beryl Capital Management LLC reports a 8.7% stake in LAVA Medtech Acquisition Corp. |
| 11/04/2021 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits |
| 11/01/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"Underwriting Agreement, by and between the Company and RBC Capital Markets, LLC, as representative of the several underwriters",
"Amended and Restated Certificate of Incorporation, filed on October 26, 2021",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its officers, its directors and LAVA Medtech Sponsor LP",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, by and among the Company and LAVA Medtech Sponsor LP",
"Private Placement Warrants Purchase Agreement, by and between the Company and LAVA Medtech Sponsor LP",
"Administrative Services Agreement, by and between the Company and LAVA Medtech Sponsor LP",
"Indemnity Agreement, by and between the Company and Anthony Natale",
"Indemnity Agreement, by and between the Company and Gerry Brunk" |
|
| 10/28/2021 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 10/27/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/26/2021 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 10/25/2021 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 10/15/2021 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 10/01/2021 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |